Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,975.10
+12.30 (0.63%)
Sep 11, 2026, 3:29 PM IST
Emcure Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹2,226. The average 1-year stock price forecast is 12.68% higher than the current stock price, while the lowest is ₹1,900 (-3.80%) and the highest is ₹2,362 (+19.59%).
Price Target: ₹2,226 (+12.68%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 12, 2026.
Analyst Ratings
The average analyst rating for Emcure Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹2,100 → ₹2,320 | Buy | Maintains | ₹2,100 → ₹2,320 | +17.46% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
105.93B
from 92.04B
Increased by 15.10%
Revenue Next Year
119.69B
from 105.93B
Increased by 12.99%
EPS This Year
63.06
from 52.29
Increased by 20.60%
EPS Next Year
77.61
from 63.06
Increased by 23.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.